PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.45%
Revenue growth under 50% of OGI.TO's 53.52%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.54%
Gross profit growth under 50% of OGI.TO's 33.33%. Michael Burry would be concerned about a severe competitive disadvantage.
-215.47%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.44%
Negative operating income growth while OGI.TO is at 32.92%. Joel Greenblatt would press for urgent turnaround measures.
-117.73%
Negative net income growth while OGI.TO stands at 284.94%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-120.58%
Negative EPS growth while OGI.TO is at 265.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-123.71%
Negative diluted EPS growth while OGI.TO is at 260.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.20%
Share reduction while OGI.TO is at 13.55%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.20%
Reduced diluted shares while OGI.TO is at 17.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-15.34%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
3.14%
Positive FCF growth while OGI.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
-43.07%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-27.65%
Negative 3Y CAGR while OGI.TO stands at 397.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-3018.29%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
67.43%
5Y OCF/share CAGR 1.25-1.5x OGI.TO's 51.37%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
-26.57%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-5286.33%
Negative 10Y net income/share CAGR while OGI.TO is at 780.84%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-248.74%
Negative 5Y net income/share CAGR while OGI.TO is 298.47%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-882.73%
Negative 3Y CAGR while OGI.TO is 2630.77%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
10337.78%
10Y equity/share CAGR above 1.5x OGI.TO's 423.47%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-34.81%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-58.34%
Negative 3Y equity/share growth while OGI.TO is at 83.53%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.36%
AR growth well above OGI.TO's 6.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.65%
Inventory shrinking or stable vs. OGI.TO's 10.67%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.65%
Negative asset growth while OGI.TO invests at 12.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.34%
Under 50% of OGI.TO's 6.28%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.77%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-42.86%
Our R&D shrinks while OGI.TO invests at 12.37%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.77%
We cut SG&A while OGI.TO invests at 22.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.